Halberd Co. (OTCMKTS:HALB) Short Interest Down 54.6% in June

Halberd Co. (OTCMKTS:HALB) was the target of a significant decline in short interest in June. As of June 30th, there was short interest totaling 186,263 shares, a decline of 54.6% from the June 15th total of 409,891 shares. Based on an average daily volume of 1,164,131 shares, the days-to-cover ratio is presently 0.2 days.

Halberd Price Performance

OTCMKTS:HALB traded down $0.00 during mid-day trading on Tuesday, reaching $0.00. The stock had a trading volume of 1,385,000 shares, compared to its average volume of 776,088. Halberd has a 12 month low of $0.00 and a 12 month high of $0.00.

About Halberd

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.